Resistance to third generation cephalosporins: the current situation

Area of Science:

• Microbiology
• Pharmacology
• Infectious Diseases

Background:

• Third-generation cephalosporins (3 GC) offer high potency against many microorganisms.
• Bacterial resistance to antibiotics is a growing clinical concern, impacting even newer drug classes.
• Emerging resistance mechanisms can render advanced antimicrobial agents ineffective.

Purpose of the Study:

• To highlight novel resistance mechanisms against third-generation cephalosporins.
• To address the clinical implications of bacterial resistance to advanced beta-lactam antibiotics.
• To underscore the threat posed by emerging resistance in gram-negative bacteria.

Main Methods:

• Review of current literature on antibiotic resistance mechanisms.
• Analysis of clinical observations regarding cephalosporin efficacy.
• Evaluation of susceptibility testing limitations for specific resistance phenotypes.

Main Results:

• Two primary resistance situations identified: high-level chromosomal cephalosporinase production and plasmid-mediated beta-lactamases.
• Chromosomal cephalosporinase can lead to in-therapy resistance in isolates initially testing susceptible.
• Plasmid-mediated beta-lactamases active against 3 GC are increasingly prevalent globally and may be underestimated by standard testing.

Conclusions:

• Bacterial resistance to third-generation cephalosporins is a significant and evolving clinical challenge.
• Novel beta-lactamase enzymes, particularly plasmid-mediated ones, pose a growing threat to antimicrobial therapy.
• Continued surveillance and improved diagnostic methods are crucial for managing emerging antibiotic resistance.